TSHA · Taysha Gene Therapies, Inc. · Share Buybacks
$4.25
+0.24 (+5.99%)
At close · Oct 27
Return incl. dividend (before tax)
Q2 2026 earnings call transcript
Market Cap
$1.36B
Shares
325.83M
Volume · Oct 27
2.82M
Avg daily vol (3M)
3.55M
Share-repurchase activity from the company's own XBRL filings — cash spent buying back common stock per fiscal year and per recent quarter, share counts where the company tagged them, and the buyback program's authorization — paired with the company's at-the-market (ATM) equity offering programs, the dilution side of the same picture. Repurchase amounts come exclusively from tagged SEC data; program figures with no tagged equivalent (untagged authorizations and all ATM figures) are read from the filing's own text and shown only after verification.
Equity Offering (ATM) Programs
| Program Established | Last Amended | Capacity | Remaining | Runs Through | Source |
|---|---|---|---|---|---|
| 2021-10 | 2025-11-04 | $212,000,000 | — | — | 10-Q , filed 2026-08-11 |
Key facts
CIK
1806310
CUSIP
877619106
13F (30d)
19 filings
19 filers
Visit website
Investor relations